Rti surgical, inc (rti) and tutogen medical gmbh (tmi), a wholly subsidiary of rti, received a complaint on (b)(6) 2021.An adverse event was reported through a post market survey for tutomesh for breast reconstruction.The survey indicated that the doctor (b)(6) (15 years' experience with the product; 10-20 cases/year), has experienced the following post-operative complications: infections, slow resorption and radiation induced fibrosis in less than 1% of cases; seroma formation in 1-5 % of the cases additional information has been requested.To date, no additional information has been received.
|